OMER Omeros Corp

Price (delayed)

$6.82

Market cap

$426.54M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.99

Enterprise value

$767.52M

Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous ...

Highlights
The EPS is up by 17% year-on-year and by 13% since the previous quarter
The net income has grown by 11% from the previous quarter and by 4.9% YoY
The gross profit has declined by 6% year-on-year but it has increased by 4.6% since the previous quarter
The revenue has contracted by 6% YoY but it has grown by 4.5% from the previous quarter
Omeros's quick ratio has plunged by 51% YoY and by 11% from the previous quarter
The debt is up by 31% year-on-year

Key stats

What are the main financial stats of OMER
Market
Shares outstanding
62.54M
Market cap
$426.54M
Enterprise value
$767.52M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
4.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.48
Earnings
Revenue
$90.52M
EBIT
-$105.11M
EBITDA
-$103.65M
Free cash flow
-$110.12M
Per share
EPS
-$1.99
Free cash flow per share
-$1.76
Book value per share
-$4.2
Revenue per share
$1.45
TBVPS
$1.97
Balance sheet
Total assets
$123.43M
Total liabilities
$386.13M
Debt
$348.4M
Equity
-$262.7M
Working capital
$48.53M
Liquidity
Debt to equity
-1.33
Current ratio
2.13
Quick ratio
1.97
Net debt/EBITDA
-3.29
Margins
EBITDA margin
-114.5%
Gross margin
98.9%
Net margin
-136.6%
Operating margin
-117.9%
Efficiency
Return on assets
-80.9%
Return on equity
N/A
Return on invested capital
-24.6%
Return on capital employed
-130.4%
Return on sales
-116.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OMER stock price

How has the Omeros stock price performed over time
Intraday
-5.28%
1 week
-12.56%
1 month
-0.87%
1 year
-45.79%
YTD
-52.27%
QTD
-50.54%

Financial performance

How have Omeros's revenue and profit performed over time
Revenue
$90.52M
Gross profit
$89.5M
Operating income
-$106.7M
Net income
-$123.66M
Gross margin
98.9%
Net margin
-136.6%
The net margin is up by 15% since the previous quarter
The operating margin has contracted by 13% YoY but it has grown by 10% from the previous quarter
The net income has grown by 11% from the previous quarter and by 4.9% YoY
The gross profit has declined by 6% year-on-year but it has increased by 4.6% since the previous quarter

Growth

What is Omeros's growth rate over time

Valuation

What is Omeros stock price valuation
P/E
N/A
P/B
N/A
P/S
4.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.48
The EPS is up by 17% year-on-year and by 13% since the previous quarter
OMER's equity is down by 7% since the previous quarter
OMER's P/S is 67% below its 5-year quarterly average of 14.2 and 60% below its last 4 quarters average of 11.7
The revenue has contracted by 6% YoY but it has grown by 4.5% from the previous quarter

Efficiency

How efficient is Omeros business performance
Omeros's ROIC has increased by 36% YoY and by 17% from the previous quarter
The return on sales is up by 21% since the previous quarter
The ROA has grown by 14% YoY but it has contracted by 3.7% from the previous quarter

Dividends

What is OMER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OMER.

Financial health

How did Omeros financials performed over time
The total assets is 68% less than the total liabilities
Omeros's quick ratio has plunged by 51% YoY and by 11% from the previous quarter
The current ratio has contracted by 48% YoY and by 10% from the previous quarter
Omeros's debt to equity has soared by 56% YoY and by 6% from the previous quarter
The debt is up by 31% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.